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measured resting MBF with positron emmission tomography using either 
O '15 water or N-13 ammonia and the myocardial response to Dob (2.5 to 40 
^g/kg/min) with transesophageal echocardiography in 15 patients (14 men; 
age 61 ±  9 years) with resting ejection fraction < 45% (mean: 30 ± 10). 
Systolic wall thickening (SWT), and MBF were measured quantitatively in 8 
anatomically matched myocardial segments in each patient. A'total of 115 
segments were available for analysis. SWT at rest ranged from -11 % to 71% 
(normal > 35%) and MBF from 0.17 to 1.7 ml/g/min (normal > 0,6). Segments 
with normal MBF had significantly greater contraction at rest compared to 
those with reduced MBF (SWT: 29.4 ± 19% vs, 14.8 ± 18%; P < 0.0001). 
Furthermore, the inotropic response to Dob was also significantly greater in 
regions with preserved MBF (increase in percent SWT: 28.6 ± 22% vs. 16.9 
± 16%; P = 0.007). A positive response to Dob (increase in percent SWT 
> 20%) was more likely in segments with normal MBF (51 of 72 [71%] vs.
14 of 43 [33%]; P = 0.0001). Thus, both resting myocardial contraction and 
the inotropic response to Dob are related to MBF. These findings suggest 
that reduced coronary blood flow is a determinant of myocardial contractile 
reserve in patients with CAD and LV systolic dysfunction.
of 56 (57%) abnormal regions. PET and MRI data in post-rev improved and 
abnormal regions follow:
Effect of Low-Density-Lipoprotein Apheresis on 
Coronary Anatomy and Regional Myocardial Blood 
Flow
Wim R. Aengevaeren, Abraham A. Kroon, Anton F. Stalenhoef, Gerard 
J. Uijen, Tjeerd van derWerf. Departments of Cardiology and General 
Internal Medicine, University Hospital Nijmegen, The Netherlands
in patients with coronary artery disease (CAD) and hypercholesterolemia 
progression of the disease is common despite treatment with lipld-lowering 
medication. LDL-Apheresis over dextran sulphate columns is a very effective 
lipld-lowering therapy which might have an beneficial effect on coronary 
anatomy and physiology.
Methods: In a randomized study we compared the effect of biweekly 
LDL-apheresis and simvastatin versus simvastatin alone. Patients with total 
cholesterol > 8 mmol/l and severe CAD were included In the study, 21 in the 
LDL-apheresis (L) group and 21 in the medication (M) group. Mean segment 
diameter (MSD) and minimal obstruction diameter (MOD) were assessed by 
QCA before and after 2 years of therapy. The regional myocardial blood flow 
was assessed by digital subtraction angiography after i.e. papaverin with 
video-densitometric calculation of the hyperemic mean transit time (HMTT),
Results: LDL-cholesterol decreased from 7.72 ± 1.96 mmol/l to a time 
averaged level of 2.95 ±1.13 (-63%) in the L group and from 7.85 ±  2.34 
mmol/l to 4.13 ±1.58 mmol/l (-43%) in the M group, QCA revealed no differ­
ences in coronary anatomy either on a patient based or on a segment based 
comparison. Paired HMTT measurements were assessed In 43 regions in 
the L group and 35 regions in the M group. Baseline values for M and L 
group were not significantly different. In the L group HMTT decreased over 2 
years in all regions from 3,35 ± 1.18 to 2.87 ±  0.82 s. (p < 0.01) versus an 
increase in the M group from to 2.95 ±  1.06 to 2.96 ± 0.90 (NS). The HMTTs 
of the LAD, RCX and RCA region contributed to the same extent in the final 
result,
Conclusions: LDL-apheresis compared to simvastatin alone lowered LDL- 
cholesterol significantly more. Both groups showed no change In coronary 
anatomy. However, regional myocardial blood flow improved in the L group. 
This functional enhancement is in accordance with previous reported results 
of excercise tests and may be a marker of recovery of endothelial function.
Recovery of Function After Revascularization Is 
Dependent on Preservation of Myocardial Blood 
Flow
Anastasia N. Kitsiou, Stephen L. Bacharach, Arshed A. Quyyumi, Ronald 
M. Summers, Vas ken Dtlsizian. NHLBI, Bethesda, Maryland
The utility of myocardial blood flow (MBF) for the evaluation of recovery of 
function after revascularization (rev) has not been well studied. In this study, 
we determined whether MBF differentiates asynergic regions that improve 
post-rev (viable) from those that remain abnormal post-rev (nonviable). We 
studied 9 pts with chronic CAD who underwent pre-rev positron emission 
tomography (PET) at rest using N-13 ammonia and F-18 deoxyglucose 
(FDG), pre- and post-rev gated magnetic resonance imaging (MRI) and 
radionuclide angiography. Mean LVEF at rest increased from 31 ±  8% pre­
rev to 38 ±  11% post-rev (p -  0.01). Absolute MBF was computed for a 
single large region in which ammonia uptake was uniform and all other 
regions were then scaled by this MBF value. 2—4 MRI and PET transaxial 
slices were matched and analyzed per patient. Pre- and post-rev systolic wall 
thickening (SWT) was assessed visually by MRI and end-diastolic (ED) and 
end-systolic (ES) wall thickness was measured quantitatively in 5 regions 
per slice. From 145 regions studied, pre-rev SWT was normal in 89 (61%) 
and abnormal in 56 (39%) regions. In normal regions, mean MBF was 0.71 
±  0.17 and FDG uptake was 0.90 ±  0.23. Post-rev, SWT improved in 32
PET MRI
Blood Flow FDG ED (mm) ES (mm)
(ml/g/min) (% uptake) pre post pre post
Improved 0.73±0.2* 0.97±0.3* 7.1 ±2.6 8.2±2.6# 8.8±4.3 10.1±3.8#
Abnormal 0.57±0.2 0.77±0.2 4.7±1.5 5.1±1.8 6.1 ±2,0 6.1 ±1.9
*p < 0.01 (Improved vs Abnormal), #p < 0.01 (pre vs post-rev)
Regions with improved SWT post-rev had higher mean MBF and FDG val­
ues compared to abnormal regions. Although there was a linear relationship 
between MBF and FDG uptake in normal (r = 0.6, p < 0.001) and abnormal 
regions that did not improve post-rev (r = 0.7, p < 0.001), the relationship 
was nonlinear In regions that improved post-rev. The latter may be explained 
by the preferentially increased FDG uptake in ischemic but viable regions, 
These data suggest that recovery of function after rev is closely related to 
preservation of MBF at a level high enough to maintain glucose utilization 
and myocyte viability.
Value of Thallium-201 Viability Imaging for 
Evaluating Prognosis in Patients With Ischemic 
Left Ventricular Dysfunction
Alessia Gimelli, Paolo Marzullo, Patrizia Landi, Silva Severi, Rosa Sicari, 
Oberdan Parodi, Antonio L’Abbate, CNR Institute of Clinical Physiology,;
Pisa, Italy
Aim of this study was to determine the long term prognostic significance 
of maintained Thallium~201 uptake in patients with ischemic left ventricular 
dysfunction. We retrospectively analized 161 patients with angiographically 
documented coronary artery disease and reduced ejection fraction (0.35 ± 
0.9) studied by Thallium-201 viability imaging (reinjection, late redistribution 
or rest studies). Thallium-201 uptake was quantified in 13 segments using 
normalized angular profiles and a viability cut-off of 54% of the peak; regional 
wall motion was assessed in the same segments using echocardiography. 
Average follow-up was 65 ± 50 months. Fifty-five/85 patients with dysfunc- 
tioning, mostly viable myocardium (> 50% of dysfunctioning segments) who 
did not undergo revascularization were more likely to experience hard events 
such as reinfarction (3 patients) or death (4 patients) when compared to the
30 successfully revascularized patients (1 death, no infarction). No signi­
ficative difference was found between patients with dominance of cell death 
treated medically (76 patients) or revascularized (17 patients). These results 
suggest that Thallium-201 viability imaging appears to identify patients at in­
creased risk of having reinfarction or death that have the most benefit from a 
revascularization procedure. Beyond short-term results, tissue viability as de­
tected by Thallium-201 may provide important prognostic information guiding 
the management of patients with ischemically compromised myocardium.
Coronary Anatomy, Stress Myocardial Perfusion 
Defects, and Ambulatory Electrocardiographic 
Ischemia. What Is the Relationship? An ACIP 
Ancillary Study
Richard M. Steingart, John J. Mahmarian, Sandra Forman, Barry L, Sharaf, 
MaryEllen Coglianese, D. Douglas Miller, A. David Goldberg, Marilyn 
F. Bloom, Sheila Byers, Laurel Dvorak, for the ACIP investigators, 
Winthrop-University Hospital, SUNY at StonyBrook, NY; Baylor College of 
Medicine, Houston, TX
Stress myocardial perfusion imaging (SPECT), ambulatory electrocardio­
graphic monitoring (AECG) and coronary arteriography (COR) were analyzed 
in 106 pts {77% men, age 61 ± 8 yrs (mean ± SD)) with > 50% coronary 
artery stenosis who had SPECT within 6 months of a screening AECG for 
enrollment in the asymptomatic cardiac ischemia pilot (ACIP) study. AECG, 
SPECT and COR were read independently in core labs. AECG ischemia was 
present in 65 pts (61%); 88 (83%) had SPECT perfusion defects (p < 0.005). 
Fifty pts were enrolled in ACIP; 56 were not. Most pts had perfusion defects 
by SPECT whether the AECG did (82%) or did not (85%) show ischemia. 
There were 2.7 ± 6.8 AECG ischemic episodes per 48 hours and SPECT 
defect size was 14 ±  14% of the left ventricle. By logistic regression meth­
ods, only ST segment depression on the exercise ECG during the SPECT 
study was associated with AECG Ischemia (p = 0.022). No other relationship 
between SPECT and AECG results was found. COR explains these find­
ings. SPECT defects were present with any > 50% coronary stenosis, while 
AECG ischemia was related to proximal coronary artery lesions (p = 0.04). 
Neither SPECT defects nor AECG ischemia were related to plaque morphol­
ogy or multivessel disease. Thus, SPECT and AECG are unrelated because 
SPECT defects are seen with any signficant coronary artery disease while 
AECG ischemia is related to proximal coronary artery lesions.
